BRIEF-Cognition Therapeutics Extends Expanded Access Program For Zervimesine (Ct1812) In Dementia With Lewy Bodies

Reuters02-05

BRIEF-Cognition <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Extends Expanded Access Program For Zervimesine (Ct1812) In Dementia With Lewy Bodies

Feb 5 (Reuters) - Cognition Therapeutics Inc CGTX.O:

COGNITION THERAPEUTICS EXTENDS EXPANDED ACCESS PROGRAM FOR ZERVIMESINE (CT1812) IN DEMENTIA WITH LEWY BODIES

Source text: ID:nGNX2xc3vQ

Further company coverage: CGTX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2609377438?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-05 20:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2609377438","market":"us","top_or_hot":-1,"title":"BRIEF-Cognition Therapeutics Extends Expanded Access Program For Zervimesine (Ct1812) In Dementia With Lewy Bodies","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Cognition <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Extends Expanded Access Program For Zervimesine (Ct1812) In Dementia With Lewy Bodies</title></head><body><p><span>Feb 5 (Reuters)</span><span> - </span>Cognition Therapeutics Inc <span>CGTX.O</span>:</p><ul><li><p>COGNITION THERAPEUTICS EXTENDS EXPANDED ACCESS PROGRAM FOR ZERVIMESINE (CT1812) IN DEMENTIA WITH LEWY BODIES</p></li></ul><p>Source text: <span>ID:nGNX2xc3vQ</span></p><p>Further company coverage: <span>CGTX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Cognition Therapeutics Extends Expanded Access Program For Zervimesine (Ct1812) In Dementia With Lewy Bodies</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Cognition Therapeutics Extends Expanded Access Program For Zervimesine (Ct1812) In Dementia With Lewy Bodies\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-05 20:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Cognition <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Extends Expanded Access Program For Zervimesine (Ct1812) In Dementia With Lewy Bodies</title></head><body><p><span>Feb 5 (Reuters)</span><span> - </span>Cognition Therapeutics Inc <span>CGTX.O</span>:</p><ul><li><p>COGNITION THERAPEUTICS EXTENDS EXPANDED ACCESS PROGRAM FOR ZERVIMESINE (CT1812) IN DEMENTIA WITH LEWY BODIES</p></li></ul><p>Source text: <span>ID:nGNX2xc3vQ</span></p><p>Further company coverage: <span>CGTX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nFWN3Z10QK:1","article_id":"2609377438","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2609377438","pubTimestamp":1770294797,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Cognition Therapeutics Extends Expanded Access Program For Zervimesine (Ct1812) In Dementia With Lewy BodiesFeb 5 (Reuters) - Cognition Therapeutics Inc CGTX.O:COGNITION THERAPEUTICS EXTENDS EXP","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","CGTX":"Cognition Therapeutics, Inc"},"translate_title":"BRIEF-Cognition Therapeutics扩展了Zervimesine(Ct1812)治疗路易体痴呆的扩展准入计划","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CGTX":0.9},"content_text":"BRIEF-Cognition Therapeutics Extends Expanded Access Program For Zervimesine (Ct1812) In Dementia With Lewy BodiesFeb 5 (Reuters) - Cognition Therapeutics Inc CGTX.O:COGNITION THERAPEUTICS EXTENDS EXPANDED ACCESS PROGRAM FOR ZERVIMESINE (CT1812) IN DEMENTIA WITH LEWY BODIESSource text: ID:nGNX2xc3vQFurther company coverage: CGTX.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2609377438","isCrawlerRequest":true}